The Pathology Vulnerability Assessment helps counsel determine whether the pathology diagnostic pathway contains material process vulnerabilities, diagnostic discordance, or case-development issues before committing to broader expert review.
The PVA is not a plaintiff tool or a defense tool. It applies the same structured four-domain review regardless of litigation posture. The value of the PVA depends on the litigation posture and the case decision counsel is trying to make.
The PVA does not replace the pathologist. A fixed-fee PVA helps counsel avoid misdirected expert spend, focus discovery, and decide whether the pathology issues warrant deeper development.
These are common triggers — not an exhaustive list. If the pathology record is part of your case and you are uncertain whether a PVA applies, that uncertainty is itself a reason to inquire. The Screening PVA is designed precisely for that moment.
If one of these triggers is present, request a fee schedule or introductory call.
Every engagement begins with a one-time master Consulting Agreement. Tier assignment is based on case complexity and your litigation objectives. All deliverables are prepared for retaining counsel and intended to support confidential attorney work-product analysis.
Early-stage triage of the complete pathology diagnostic pathway across all four PVA domains — including Diagnostic Discordance Review when multiple pathology opinions are present. Delivers a written Screening PVA Report with a case-posture assessment and recommendation regarding whether deeper pathology review appears warranted. The full $1,250 Tier I fee is credited toward Tier II when the matter proceeds to Case Development PVA.
Expanded Case Development PVA Report with phase-level findings across all four PVA domains, applicable CAP and professional standards references, pathology-process deviation analysis, and a litigation-focused narrative identifying issues for counsel and appropriate next-step expert review. One post-delivery consultation call included (60 minutes, within 30 days). Follows Tier I findings — not automatic.
Expert designation and testimony grounded in PVA methodology and findings. Available selectively when the requested opinions fall within Sentinel’s pathology-process scope, PA(ASCP) qualifications, and applicable jurisdictional requirements. Testimony minimums and cancellation terms confirmed in the Matter Engagement Form.
A redacted sample illustrating the four-domain review methodology, phase-level findings, discordance classification, and case-posture assessment. Enter your name, firm, and email — the sample downloads immediately.
Your information is used only to fulfill this request. Sentinel does not share or sell contact information.
The Pathology Vulnerability Assessment evaluates the complete pathology diagnostic pathway across four structured domains. Each domain is systematically reviewed against applicable professional standards. The methodology is consistent across both tier levels — scope and deliverable depth are determined by tier assignment.
Clinician order, patient identification, specimen collection, labeling and container preparation, chain of custody, accessioning, fixation protocol, transport conditions, and receipt at the laboratory. Published laboratory-quality literature has repeatedly identified the pre-analytical phase as a primary source of laboratory error — occurring before the pathologist is involved.
Gross examination and tissue sampling, histologic processing and staining, microscopic examination, IHC and ancillary testing, and quality control. Gross examination is a critical analytical checkpoint — the pathologist can only diagnose what was sampled and processed correctly.
Report generation, diagnosis completeness and clarity, CAP synoptic protocol compliance, critical value notification, amendments and addenda handling, specimen and slide retention, and clinical consultation between the pathologist and treating physician.
When multiple pathology reports, outside consultations, amended reports, or second opinions exist, Sentinel identifies whether they contain materially different diagnostic conclusions and explains the potential significance of that discordance for counsel’s case evaluation. Sentinel does not determine which diagnosis is correct — it advises counsel whether the discordance warrants pathologist review, targeted discovery, or additional record development. This is the PVA’s cost-triage function for cases involving conflicting pathology opinions.
Submit an inquiry through the form below or by direct email. Sentinel will reply promptly by email to schedule an introductory call. The call is confidential and no-obligation — no privileged details are required at this stage.
A one-time master Consulting Agreement is executed. This covers all future matters from your firm and does not need to be re-executed for each new case.
A Matter Engagement Form is completed for each new case. Conflict screening is completed before any records are accepted or work begins. Sentinel does not accept matters where a conflict of interest exists.
The Pathology Vulnerability Assessment is conducted across four domains — Pre-Analytical, Analytical, Post-Analytical, and Diagnostic Discordance Review. Each domain is reviewed against applicable CAP, ASCO, Joint Commission, and laboratory accreditation standards. Diagnostic Discordance Review identifies materially different diagnostic conclusions between available pathology opinions without independently adjudicating the correct diagnosis. Scope is consistent across tiers; depth and deliverable format are determined by tier assignment.
Tier I produces a written Screening PVA Report with a case-posture assessment and recommendation regarding whether deeper pathology review appears warranted. Tier II produces a Case Development PVA Report with full four-domain analysis, phase-level findings, applicable standards references, and a litigation-focused narrative. Both are prepared for retaining counsel and intended to support confidential attorney work-product analysis. Tier upgrades are available at any point based on findings or matter needs.
Select what you need below. No privileged case details required at this stage. Conflict screening and engagement terms are handled after initial contact.
Sentinel will reply promptly by email. No privileged case details required at this stage.